{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:07:04Z","timestamp":1773317224687,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.physbeh.2024.114506","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T12:07:20Z","timestamp":1709294840000},"page":"114506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Additive anxiolytic-like effect of citicoline and ACPA in the non-acute restraint stress (NARS) and acute restraint stress (ARS) mice"],"prefix":"10.1016","volume":"277","author":[{"given":"Aysan","family":"Amnzade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Reza","family":"Zarrindast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7395-9974","authenticated-orcid":false,"given":"Fatemeh","family":"Khakpai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2024.114506_bib0001","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fnmol.2018.00424","article-title":"Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression","volume":"11","author":"Stampanoni Bassi","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114506_bib0002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuroscience.2011.07.052","article-title":"Cannabinoids and emotionality: a neuroanatomical perspective","volume":"204","author":"McLaughlin","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2024.114506_bib0003","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/10253890.2011.586753","article-title":"Endocannabinoids and stress","volume":"14","author":"Riebe","year":"2011","journal-title":"Stress"},{"key":"10.1016\/j.physbeh.2024.114506_bib0004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuroscience.2011.12.035","article-title":"Neuronal populations mediating the effects of endocannabinoids on stress and emotionality","volume":"204","author":"H\u00e4ring","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2024.114506_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158950","article-title":"Putative epigenetic involvement of the endocannabinoid system in anxiety-and depression-related behaviors caused by nicotine as a stressor","volume":"11","author":"Hayase","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.physbeh.2024.114506_bib0006","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2174\/1570159X12666140923205412","article-title":"The endocannabinoid\/endovanilloid system and depression","volume":"12","author":"Smaga","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.physbeh.2024.114506_bib0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1745-0179-3-25","article-title":"A possible role for the endocannabinoid system in the neurobiology of depression","volume":"3","author":"Serra","year":"2007","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.physbeh.2024.114506_bib0008","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-3-540-88955-7_14","article-title":"Role of endocannabinoid signaling in anxiety and depression","volume":"1","author":"Patel","year":"2009","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.physbeh.2024.114506_bib0009","first-page":"S7","article-title":"[Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?]","volume":"32","author":"Saito","year":"2010","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2024.114506_bib0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2005.10.006","article-title":"A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders","volume":"26","author":"Witkin","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.physbeh.2024.114506_bib0011","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bj.2016.11.006","article-title":"Spinal cord regeneration by modulating bone marrow with neurotransmitters and Citicholine: analysis at micromolecular level","volume":"40","author":"Paulose","year":"2017","journal-title":"Biomed. J."},{"key":"10.1016\/j.physbeh.2024.114506_bib0012","unstructured":"Secades, J.J., Lorenzo, J.L. Citicoline: pharmacological and clinical review, 2006 update. Methods and findings in experimental and clinical pharmacology. 2006,28 Suppl B:1\u201356."},{"key":"10.1016\/j.physbeh.2024.114506_bib0013","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/01616412.1995.11740327","article-title":"Citicoline (CDP-choline): mechanisms of action and effects in ischemic brain injury","volume":"17","author":"D'Orlando","year":"1995","journal-title":"Neurol. Res."},{"key":"10.1016\/j.physbeh.2024.114506_bib0014","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11064-004-9681-8","article-title":"Cytidine 5\u2032-diphosphocholine (CDP-choline) in stroke and other CNS disorders","volume":"30","author":"Adibhatla","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.physbeh.2024.114506_bib0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/00952990.2014.925467","article-title":"Citicoline in addictive disorders: a review of the literature","volume":"40","author":"Wignall","year":"2014","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.physbeh.2024.114506_bib0016","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1358\/mf.2009.31.3.1364241","article-title":"Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases","volume":"31","author":"Cho","year":"2009","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114506_bib0017","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40263-014-0144-8","article-title":"Neuroprotective properties of citicoline: facts, doubts and unresolved issues","volume":"28","author":"Grieb","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.physbeh.2024.114506_bib0018","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jad.2012.05.006","article-title":"A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence","volume":"143","author":"Brown","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.physbeh.2024.114506_bib0019","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejphar.2016.07.048","article-title":"Evaluation of neuroprotective, anticonvulsant, sedative and anxiolytic activity of citicoline in rats","volume":"789","author":"Abdolmaleki","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114506_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2015.01.051","article-title":"Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system","volume":"284","author":"Kruk-Slomka","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2024.114506_bib0021","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/j.1460-9568.2007.05422.x","article-title":"Endocannabinoids mediate muscarine-induced synaptic depression at the vertebrate neuromuscular junction","volume":"25","author":"Newman","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114506_bib0022","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00213-015-4196-3","article-title":"Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives","volume":"233","author":"Scherma","year":"2016","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.physbeh.2024.114506_bib0023","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.physbeh.2024.114506_bib0024","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1476-5381.2011.01384.x","article-title":"The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor \u03b1 protein","volume":"164","author":"Fiori","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114506_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136095","article-title":"Synergistic effect between imipramine and citicoline upon induction of analgesic and antidepressant effects in mice","volume":"760","author":"Khakpai","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.physbeh.2024.114506_bib0026","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbr.2015.05.006","article-title":"Acute restraint stress and corticosterone transiently disrupts novelty preference in an object recognition task","volume":"291","author":"Vargas-Lopez","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2024.114506_bib0027","first-page":"1","article-title":"Synergistic antidepressant- and anxiolytic-like effects of harmaline along with cinanserin in acute restraint stress-treated mice","author":"Mosaffa","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.physbeh.2024.114506_bib0028","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nrn2639","article-title":"Effects of stress throughout the lifespan on the brain, behaviour and cognition","volume":"10","author":"Lupien","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114506_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.113034","article-title":"Combined treatment of scopolamine and group III mGluR antagonist, CPPG, exerts antidepressant activity without affecting anxiety-related behaviors","volume":"224","author":"Ebrahimi-Ghiri","year":"2020","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2024.114506_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114506_bib0031","first-page":"292","article-title":"Neural regulation of the stress response: glucocorticoid feedback mechanisms","volume":"45","author":"Herman","year":"2012","journal-title":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas \/Sociedade Brasileira de Biofisica"},{"key":"10.1016\/j.physbeh.2024.114506_bib0032","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbr.2011.10.007","article-title":"Effects of acute restraint stress on different components of memory as assessed by object-recognition and object-location tasks in mice","volume":"227","author":"Li","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2024.114506_bib0033","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.0504011102","article-title":"Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala","volume":"102","author":"Mitra","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.physbeh.2024.114506_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2023.100537","article-title":"Poststress social isolation exerts anxiolytic effects by activating the ventral dentate gyrus","volume":"24","author":"Lei","year":"2023","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.physbeh.2024.114506_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/npr2.12093","article-title":"Differential effects of stress exposure via two types of restraint apparatuses on behavior and plasma corticosterone level in inbred male BALB\/cAJcl mice","volume":"40","author":"Shoji","year":"2020","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.physbeh.2024.114506_bib0036","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pnpbp.2012.05.018","article-title":"Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex","volume":"39","author":"Chiba","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2024.114506_bib0037","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1046\/j.1460-9568.2003.02548.x","article-title":"One-trial sensitization'to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze","volume":"17","author":"Rodgers","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114506_bib0038","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/FBP.0b013e32832c70b1","article-title":"Interactions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission","volume":"20","author":"Mikics","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114506_bib0039","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.tpj.6500466","article-title":"Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice","volume":"8","author":"Steiner","year":"2008","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.physbeh.2024.114506_bib0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008877-200509000-00005","article-title":"A role for cannabinoid CB1 receptors in mood and anxiety disorders","volume":"16","author":"Witkin","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114506_bib0041","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2009.06.006","article-title":"The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants","volume":"30","author":"Hill","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.physbeh.2024.114506_bib0042","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.physbeh.2024.114506_bib0043","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2147\/NDT.S167538","article-title":"Addictive potential of novel treatments for refractory depression and anxiety","volume":"14","author":"Kolar","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.physbeh.2024.114506_bib0044","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/brainsci3031395","article-title":"The role of citicoline in neuroprotection and neurorepair in ischemic stroke","volume":"3","author":"Alvarez-Sabin","year":"2013","journal-title":"Brain Sci."},{"key":"10.1016\/j.physbeh.2024.114506_bib0045","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/JCP.0b013e31814db4c4","article-title":"A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence","volume":"27","author":"Brown","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.physbeh.2024.114506_bib0046","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0006-8993(00)03280-7","article-title":"Does CDP-choline modulate phospholipase activities after transient forebrain ischemia?","volume":"893","author":"Rao","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2024.114506_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146701","article-title":"Synergistic effect between citalopram and citicoline on anxiolytic effect in non-sensitized and morphine-sensitized mice: an isobologram analysis","volume":"1734","author":"Nejati","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2024.114506_bib0048","article-title":"Cannabinoid agonists possibly mediate interaction between cholinergic and cannabinoid systems in regulating intestinal inflammation","volume":"139","author":"de Aguiar Magalh\u00e3es","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.physbeh.2024.114506_bib0049","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.neuropharm.2011.07.039","article-title":"Modulation of endocannabinoid-mediated long-lasting disinhibition of striatal output by cholinergic interneurons","volume":"61","author":"Adermark","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2024.114506_bib0050","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1523\/JNEUROSCI.5303-10.2011","article-title":"Physiological activation of cholinergic inputs controls associative synaptic plasticity via modulation of endocannabinoid signaling","volume":"31","author":"Zhao","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114506_bib0051","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.physbeh.2024.114506_bib0052","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00213-007-0813-0","article-title":"Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling","volume":"194","author":"Kodas","year":"2007","journal-title":"Psychopharmacology (Berl.)"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938424000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938424000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:26:36Z","timestamp":1758479196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938424000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":52,"alternative-id":["S0031938424000519"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2024.114506","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additive anxiolytic-like effect of citicoline and ACPA in the non-acute restraint stress (NARS) and acute restraint stress (ARS) mice","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2024.114506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114506"}}